Emerging paradigms in cancer cell plasticity

키워드

참고문헌 (76)

1. Mehlen P, "Metastasis : a question of life or death", Nat Rev Cancer, 6, pp.449~458 (2006)
2. Gupta GP, "Cancer metastasis : building a framework", Cell, 127, pp.679~695 (2006)
3. Stuelten CH, "Cell motility in cancer invasion and metastasis : insights from simple model organisms", Nat Rev Cancer, 18, pp.296~312 (2018)
4. Reymond N, "Crossing the endothelial barrier during metastasis", Nat Rev Cancer, 13, pp.858~870 (2013)
5. Micalizzi DS, "A conduit to metastasis : circulating tumor cell biology", Genes Dev, 31, pp.1827~1840 (2017)
6. Wirtz D, "The physics of cancer : the role of physical interactions and mechanical forces in metastasis", Nat Rev Cancer, 11, pp.512~522 (2011)
7. Massague J, "Metastatic colonization by circulating tumour cells", Nature, 529, pp.298~306 (2016)
8. Perez-Gonzalez A, "Cancer cell plasticity during tumor progression, metastasis and response to therapy", Nat Cancer, 4, pp.1063~1082 (2023)
9. Kim OH, "Role of extrinsic physical cues in cancer progression", BMB Rep, 56, pp.287~295 (2023)
10. Huyghe A, "Cellular plasticity in reprogramming, rejuvenation and tumorigenesis : a pioneer TF perspective", Trends Cell Biol, 34, pp.255~267 (2024)
11. Takahashi K, "Induction of pluripotent stem cells from adult human fibroblasts by defined factors", Cell, 131, pp.861~872 (2007)
12. Takahashi K, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors", Cell, 126, pp.663~676 (2006)
13. Ambasudhan R, "Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions", Cell Stem Cell, 9, pp.113~118 (2011)
14. Ieda M, "Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors", Cell, 142, pp.375~386 (2011)
15. Pereira CF, "Induction of a hemogenic program in mouse fibroblasts", Cell Stem Cell, 13, pp.205~218 (2013)
16. da Silva-Diz V, "Cancer cell plasticity : impact on tumor progression and therapy response", Semin Cancer Biol, 53, pp.48~58 (2018)
17. Nieto MA, "Emt : 2016", Cell, 166, pp.21~45 (2016)
18. Huh HD, "Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic dissemination", Mol Cancer, 22, pp.63~ (2023)
19. Marabitti V, "Should I stay or should I go? Spatio-temporal control of cellular anchorage by hematopoietic factors orchestrates tumor metastatic cascade", Mol Cancer, 22, pp.149~ (2023)
20. Lamouille S, "Molecular mechanisms of epithelial-mesenchymal transition", Nat Rev Mol Cell Biol, 15, pp.178~196 (2014)
21. Huang Y, "The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis", J Hematol Oncol, 15, pp.129~ (2022)
22. Yang J, "Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis", Cell, 117, pp.927~939 (2004)
23. Ni T, "Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer", Nat Cell Biol, 18, pp.1221~1232 (2016)
24. Krebs AM, "The EMTactivator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer", Nat Cell Biol, 19, pp.518~529 (2017)
25. Sun BO, "Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression", Biomed Rep, 3, pp.603~610 (2015)
26. Hong O, "Aurora kinase A induces migration and invasion by inducing epithelial-tomesenchymal transition in colon cancer cells", BMB Rep, 55, pp.87~91 (2022)
27. Shi X, "Cancer-associated fibroblasts facilitate squamous cell carcinoma lung metastasis in mice by providing TGFbeta-mediated cancer stem cell niche", Front Cell Dev Biol, 9, pp.668164~ (2021)
28. Tsai JH, "Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis", Cancer Cell, 22, pp.725~736 (2012)
29. Kallergi G, "Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients", Breast Cancer Res, 11, pp.R84~ (2009)
30. Chen P, "Role of matrix metalloproteinases in epithelial migration", J Cell Biochem, 108, pp.1233~1243 (2009)
31. Grzechocinska B, "Serum levels and tissue expression of matrix metalloproteinase 2(MMP-2)and tissue inhibitor of metalloproteinases 2(TIMP-2)in colorectal cancer patients", Tumour Biol, 35, pp.3793~3802 (2014)
32. Dhar M, "Functional profiling of circulating tumor cells with an integrated vortex capture and single-cell protease activity assay", Proc Natl Acad Sci U S A, 115, pp.9986~9991 (2018)
33. Cao Z, "Anoikis and EMT : lethal Liaisons during cancer progression", Crit Rev Oncog, 21, pp.155~168 (2016)
34. Williams ED, "Controversies around epithelial-mesenchymal plasticity in cancer metastasis", Nat Rev Cancer, 19, pp.716~732 (2019)
35. Gao J, "TGF-beta isoforms induce EMT independent migration of ovarian cancer cells", Cancer Cell Int, 14, pp.72~ (2014)
36. Chung YC, "Rab11 collaborates E-cadherin to promote collective cell migration and indicates a poor prognosis in colorectal carcinoma", Eur J Clin Invest, 46, pp.1002~1011 (2016)
37. Cheung KJ, "Collective invasion in breast cancer requires a conserved basal epithelial program", Cell, 155, pp.1639~1651 (2013)
38. Aceto N, "Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis", Cell, 158, pp.1110~1122 (2014)
39. Gkountela S, "Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding", Cell, 176, pp.98~112 (2019)
40. Mu Z, "Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer", Breast Cancer Res Treat, 154, pp.563~571 (2015)
41. Wang C, "Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer", Breast Cancer Res Treat, 161, pp.83~94 (2017)
42. Murlidhar V, "Poor prognosis indicated by venous circulating tumor cell clusters in early-stage lung cancers", Cancer Res, 77, pp.5194~5206 (2017)
43. Krol I, "Detection of circulating tumour cell clusters in human glioblastoma", Br J Cancer, 119, pp.487~491 (2018)
44. Jansson S, "Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort", BMC Cancer, 16, pp.433~ (2016)
45. Klameth L, "Small cell lung cancer : model of circulating tumor cell tumorospheres in chemoresistance", Sci Rep, 7, pp.5337~ (2017)
46. Fischer KR, "Epithelial-tomesenchymal transition is not required for lung metastasis but contributes to chemoresistance", Nature, 527, pp.472~476 (2015)
47. Zheng X, "Epithelial-tomesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer", Nature, 527, pp.525~530 (2015)
48. Seng A, "The role of the ikaros family of transcription factors in regulatory T cell development and function", J Clin Cell Immunol, 8, pp.495~ (2017)
49. Sellars M, "Ikaros in B cell development and function", World J Biol Chem, 2, pp.132~139 (2011)
50. Andrews NC, "Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein", Nature, 362, pp.722~728 (1993)
51. Tamura T, "Regulation of myelopoiesis by the transcription factor IRF8", Int J Hematol, 101, pp.342~351 (2015)
52. Tijchon E, "Tumor suppressors BTG1 and BTG2 regulate early mouse B-cell development", Haematologica, 101, pp.e272~e276 (2016)
53. Dupont S, "Role of YAP", TAZ in mechanotransduction, 2011, pp.474, 179~183
54. Nardone G, "YAP regulates cell mechanics by controlling focal adhesion assembly", Nat Commun, 8, pp.15321~ (2017)
55. Lee YC, "Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP", TAZ inhibition, 2022, pp.41, 757~769
56. Shin JE, "Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia", Mol Cancer, 22, pp.177~ (2023)
57. Labuschagne CF, "Cell clustering promotes a metabolic switch that supports metastatic colonization", Cell Metab, 30, pp.720~734 (2019)
58. Zheng Y, "Expression of beta-globin by cancer cells promotes cell survival during blood-borne dissemination", Nat Commun, 8, pp.14344~ (2017)
59. Krönke J, "Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells", Science, 343, pp.301~305 (2014)
60. Lu G, "The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins", Science, 343, pp.305~309 (2014)
61. Bras GFL, "The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression", Cell Adh Migr, 6, pp.365~373 (2012)
62. Huh HD, "Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic dissemination", Mol Cancer, 22, pp.63~ (2023)
63. Yuan Z, "Extracellular matrix remodeling in tumor progression and immune escape : from mechanisms to treatments", Mol Cancer, 22, pp.48~ (2023)
64. Haerinck J, "The epithelialmesenchymal plasticity landscape : principles of design and mechanisms of regulation", Nat Rev Genet, 24, pp.590~609 (2023)
65. Meyer-Schaller N, "A hierarchical regulatory landscape during the multiple stages of EMT", Dev Cell, 48, pp.539~553 (2019)
66. Jolly MK, "Stability of the hybrid epithelial", mesenchymal phenotype, 2016, pp.7, 27067~27084
67. Yang J, "Guidelines and definitions for research on epithelial-mesenchymal transition", Nat Rev Mol Cell Biol, 21, pp.341~352 (2020)
68. Pastushenko I, "Identification of the tumour transition states occurring during EMT", Nature, 556, pp.463~468 (2018)
69. Lüönd F, "Distinct contributions of partial and full EMT to breast cancer malignancy", Dev Cell, 56, pp.3203~3221 (2021)
70. Nieto MA, "Epithelial plasticity : a common theme in embryonic and cancer cells", Science, 342, pp.1234850~ (2013)
71. Hu Y, "Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia", Genes Dev, 30, pp.1971~1990 (2016)
72. Joshi I, "Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia", Nat Immunol, 15, pp.294~304 (2014)
73. Churchman ML, "Efficacy of retinoids in IKZF1-mutated BCR-ABL1 acute lymphoblastic leukemia", Cancer Cell, 28, pp.343~356 (2015)
74. Churchman ML, "Synergism of FAK and tyrosine kinase inhibition in Ph(+)B-ALL", JCI Insight, 1, pp.e86082~ (2016)
75. Churchman ML, "Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia", Cancer Cell, 33, pp.937~948 (2018)
76. Andrews NC, "Erythroid transcription factor NF-E2coordinates hemoglobin synthesis", Pediatr Res, 36, pp.419~423 (1994)